It aims to provide trained healthcare manpower, home care solutions, and end-to-end hospital management services enabling quick & on-demand deployment
The government plans to enrol over 50 crore people and empanel more hospitals under the scheme. The scheme provides a cover of Rs 5 lakh per family per year
FDA approval of the first interchangeable biosimilar insulin will drive the US Insulin biosimilar market, says Kuick Research.
Seen in 1 in 3 million births, the malformation was detected at the antenatal stage during the mother's pregnancy
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
The project is a collaboration between IIT Delhi and AIIMS
Investment of Rs 235 crores to add 411 beds in the next 18 months
It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
The company has tied up with OrbiMed as a financial partner for global reach
Subscribe To Our Newsletter & Stay Updated
